HIGHLIGHTS
- who: Keli L. Hippen and collaborators from the Sevilla University, Spain have published the Article: Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease, in the Journal: (JOURNAL)
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Treg also use metabolic intermediates to suppress T_cell activation, including extracellular production of adenosine through the concordant expression of CD39 and CD73 and the direct transfer of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.